Research has found that artificial chatbots are already being used by patients as diagnostic tools to identify symptoms.1
Several medical specialties such as pneumonia in radiology, dermatology, pathology and cardiology have conducted studies where artificial intelligence (AI) has met or exceeded the same standard as experts in image-based diagnoses.1
Water usage in some AI centres is estimated to rise to 4.2-6.6 billion cubic metres in 2027. This is the equivalent of over half of the UK’s annual water use from 2023.2
A recent use of AI in a pharmaceutical setting has been credited with having identified a solution to the ‘protein folding problem’, which had not been solved in 50 years.3
Despite their usefulness, at least one chatbot search requires almost three times the amount of electricity as a single search on other leading search engines.4